Stay updated on Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial
Sign up to get notified when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.
Latest updates to the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page
- Check4 days agoChange DetectedLocations are now listed under a single Locations section with sites across US states and Canadian provinces; the page shows a Revision: v3.3.3.SummaryDifference2%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.3.2 has been added and the previous v3.3.1 revision has been removed.SummaryDifference0.0%
- Check32 days agoChange DetectedAdded a note that publications are automatically pulled from PubMed and may not relate to the study, and updated the revision to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check40 days agoChange DetectedThe notice about a lapse in government funding was removed from the page. This is a non-significant change to page messaging; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check54 days agoChange DetectedNo meaningful changes detected in the Study Details page between the two screenshots; core information remains the same.SummaryDifference0.3%
- Check83 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%
Stay in the know with updates to Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.